Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticles

STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES I. QUANTITATIVE RELATION BETWEEN DOSAGE OF PHYSOSTIGMINE AND INHIBITION OF CHOLINESTERASE ACTIVITY IN THE BLOOD SERUM OF DOGS

OTTO KRAYER, AVRAM GOLDSTEIN and FRANK L. PLACHTE
Journal of Pharmacology and Experimental Therapeutics January 1944, 80 (1) 8-30;
OTTO KRAYER
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AVRAM GOLDSTEIN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FRANK L. PLACHTE
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

1. The time course of the inhibition of serum cholinesterase activity has been followed in detail after single intravenous doses of physostigmine in dogs.

2. With continuous intravenous infusions of physostigmine in dogs a steady level of inhibited serum cholinesterase activity is reached within one hour and may be maintained for as long as the infusion lasts.

3. The percentage level of serum cholinesterase inhibition attained by a constant rate of infusion is reproducible and allows quantitative definition of "eserinization" when employed for physiological experiments involving cholinergic mechanisms.

4. The kidneys are proved to play a minor rôle in the disposal of physostigmine.

5. The recovery of serum cholinesterase activity in vivo after continuous infusion and after large single doses appears to follow a mechanism similar to the recovery of the inhibited enzyme activity in vitro.

6. The validity of determinations of inhibited enzymes is discussed from the standpoint of the various methods which may be employed in such determinations. Combination of inhibitor with enzyme, destruction of inhibitor, dilution, displacement of inhibitor by substrate, and time are shown to be among the factors by which methods differ, and which require proper correction. A basis is provided for understanding and evaluating the unfamiliar corrections applied to the data presented in this paper.

Footnotes

    • Received August 4, 1943.

JPET articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 80, Issue 1
1 Jan 1944
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES I. QUANTITATIVE RELATION BETWEEN DOSAGE OF PHYSOSTIGMINE AND INHIBITION OF CHOLINESTERASE ACTIVITY IN THE BLOOD SERUM OF DOGS
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticles

STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES I. QUANTITATIVE RELATION BETWEEN DOSAGE OF PHYSOSTIGMINE AND INHIBITION OF CHOLINESTERASE ACTIVITY IN THE BLOOD SERUM OF DOGS

OTTO KRAYER, AVRAM GOLDSTEIN and FRANK L. PLACHTE
Journal of Pharmacology and Experimental Therapeutics January 1, 1944, 80 (1) 8-30;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticles

STUDIES ON PHYSOSTIGMINE AND RELATED SUBSTANCES I. QUANTITATIVE RELATION BETWEEN DOSAGE OF PHYSOSTIGMINE AND INHIBITION OF CHOLINESTERASE ACTIVITY IN THE BLOOD SERUM OF DOGS

OTTO KRAYER, AVRAM GOLDSTEIN and FRANK L. PLACHTE
Journal of Pharmacology and Experimental Therapeutics January 1, 1944, 80 (1) 8-30;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

Articles

  • 4-Methylcatechol Increases Brain-Derived Neurotrophic Factor Content and mRNA Expression in Cultured Brain Cells and in Rat Brain In Vivo
  • Glucocorticoid Enhances Interleukin-1-Induced Pressor Response in Freely Moving Rats Through Its Effect on Nitric Oxide Release
  • N-Oxygenation of Amphetamine and Methamphetamine by the Human Flavin-Containing Monooxygenase (Form 3): Role in Bioactivation and Detoxication
Show more Articles

Article

  • 4-Methylcatechol Increases Brain-Derived Neurotrophic Factor Content and mRNA Expression in Cultured Brain Cells and in Rat Brain In Vivo
  • Glucocorticoid Enhances Interleukin-1-Induced Pressor Response in Freely Moving Rats Through Its Effect on Nitric Oxide Release
  • N-Oxygenation of Amphetamine and Methamphetamine by the Human Flavin-Containing Monooxygenase (Form 3): Role in Bioactivation and Detoxication
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics